Janus Henderson Group PLC Invitae Corp Transaction History

Janus Henderson Group PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.2 - $2.73 $65,250 - $148,443	54,375 Added 158.44%	88,694 $119,000
Q3 2022 Nov 14, 2022	BUY	$1.9 - $8.63 $169 - $768	89 Added 0.26%	34,319 $85,000
Q2 2022 Aug 15, 2022	SELL	$2.13 - $9.01 $87 - $369	-41 Reduced 0.12%	34,230 $83,000
Q1 2022 May 16, 2022	BUY	$6.28 - $15.59 $408 - $1,013	65 Added 0.19%	34,271 $273,000
Q4 2021 Feb 14, 2022	BUY	$14.7 - $28.67 $254,089 - $495,560	17,285 Added 102.15%	34,206 $522,000
Q3 2021 Nov 16, 2021	BUY	$24.31 - $33.6 $411,349 - $568,545	16,921 New	16,921 $481,000

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.